Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy
- 12 November 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (20) , 2526-2529
- https://doi.org/10.1161/01.cir.0000038419.53000.d6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)Circulation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Cholesterol Lowering in the Elderly PopulationArchives of internal medicine (1960), 1999
- Comparison of Factors Associated With 30-Day Mortality After Coronary Artery Bypass Grafting in Patients With Versus Without Diabetes MellitusThe American Journal of Cardiology, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100Atherosclerosis, 1993
- National Cholesterol Education ProgramArchives of internal medicine (1960), 1991
- Does measurement of apolipoprotein B have a place in cholesterol management?Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Management of Dyslipidemia in NIDDMDiabetes Care, 1990
- Epidemiology as a Guide to Clinical DecisionsNew England Journal of Medicine, 1980